Activation of mGlu2/3 receptors, a novel therapeutic approach to alleviate dyskinesia and psychosis in experimental parkinsonism

2019/07/25 by Imane Frouni, Adjia Hamadjida, Cynthia Kwan +7 · 1 citation
Neuroscience · Medicine · #Neuroscience and Neuropharmacology Research #Parkinson's Disease Mechanisms and Treatments #Neurological disorders and treatments

paper · doi:10.1016/j.neuropharm.2019.107725

Citations

• l-DOPA pharmacokinetics in the MPTP-lesioned macaque model of Parkinson's disease

Cited by

• Combined 5-HT2A and mGlu2 modulation for the treatment of dyskinesia and psychosis in Parkinson's disease